Products

Suppliers

News

All Categories

Products or Suppliers

Content Hub

Product Zone

Sponsorship & Membership

CPHI & PMEC China

Active Pharmaceutical Ingredients Intermediates&Fine Chemicals Bio Products Natural Extracts Finished Dosage Pharmaceutical Excipients Pharmaceutical Outsourcing, Customised Services, and Consulting Medical Aesthetic Skincare Food Ingredients API Equipment Preparation Equipment Pharmaceutical Packaging Machinery TCM Machinery Pharmaceutical water equipment Clean Technology Refrigeration Equipment Parts and Components Informatization Products Laboratory Packaging Materials Measuring Instrument Environmental Protection Equipment Logistics Other Consumables Dietary Supplements‌‌

Correctives Colorant Filtration separation Intelligent Logistics Cold chain Technical &Materials Logistics Equipment &Materials Storage Equipment &Materials Logistic Services Third-party logistics Dangerous Goods Logistics Level instrument Pressure gauge Thermometers Flow meter Gas analysis instrument Liquid analysis instrument Fermenter Equipment Other Measuring Instrument Other Logistics Medical Aesthetic Consumables Sera and Vaccines Soft tube/Hard tube Pharmaceutical Intermediates Anti-tumor Preparations Pharmaceutical Manufacturing Outsourcing Chemical and Biochemical Reactors Mixing Equipment CIP System(Clean in place) Herbal medicine Concentration Equipment Purification Equipment Low Temperature Refrigeration Seals Laboratory General Equipment Functional Food Raw Materials Inner packaging equipment Polluted Water / Wastewater Treatment Equipment Injection Raw Materials and Ingredients IVD (In Vitro Diagnostics) Consumables Suspending Agents / Thickening Agents Concentrator Equipment MES System APIs for Anti-Infective Drugs Biochemical APIs Botanical products Pharma Packaging Materials Diluents (Fillers) Intermediates for Agrochemicals Reagent Cardiovascular, Cerebrovascular, and Circulatory System Formulations Pharmaceutical R&D Outsourcing Drying Equipment TCM Pulverizer Water Purification Equipment Purification Test Instrument Air Conditioner ‌Sanitary Fittings Analytical Instrument Other Dipstick Consumables Nutraceutical Ingredients Granules Machinery Outer packaging Waste Gas Treatment Equipment Active Ingredients Binders Solubilizers Drug delivery systems Sensors APIs for Nervous System Drugs Animal-derived products Endocrine and Metabolic Preparations Disintegrants service Crystalling Equipment Pill Making Equipment Other Water Treatment Equipment Clean Clothes/Clean Cap/Clean Shoes Cold Storage Pumps Food & Beverage Raw Materials Life Science Instrument Tablet equipment Other pharmaceutical packaging equipment Solid and Hazardous Waste Treatment Equipment Innovative Materials Controllers & Drivers Speciality Intermediates Microbial products Humectants APIs for Digestive System Drugs APIs for Cardiovascular System Drugs Antibacterial and Antiviral Formulations Lubricants Extraction Plant Slice Machine Clean Bench ‌Refrigeration Auxiliaries Valves Biologics TCM Raw Materials Food Additive Reagents and Consumables Capsule equipment Pharmaceutical water equipment Testing & Monitoring Instruments and Equipment Other Medical Aesthetics & Skincare Veterinary Pharmaceutical Intermediates Automation Software APIs for Respiratory System Drugs Bio Technology Service Antipyretic and Analgesic Preparations Glidants / Anti-caking Agents Heat Exchanger Herbal medicine Drying Equipment Air Shower Room Compressor Cylinders Fine Chemicals Crushing equipment Ultrapure Water System Other Automation & Informatization Products OEM/ODM Measuring Instruments Energy-saving and Low-carbon Equipment Other Intermediates Antiparasitic Preparations Coating Agents Storage Tanks, Containers Herbal medicine Extraction Equipment Air Purification Other Refrigeration Equipment Drive Equipment‌ Liquid preparation equipment Solution Preparation System Other Environmental Protection Equipment APIs for Hormones and Regulatory Drugs Other Natural Products Physical Testing APIs for Antiparasitic Drugs Anti-Allergic Formulations Plasticizer Evaporating Equipment TCM Cooking Equipments Cleanroom Reducers Laboratory Engineering Biopharmaceutical Equipment Membrane Module‌ APIs for Antipyretic and Analgesic Drugs Anti-Tuberculosis and Anti-Leprosy Formulations Surfactant Distillation Equipment Drop Pill Equipment Purifying Engineering VFD (Variable Frequency Drive) Other preparation equipment Distilled water machine Laboratory Solutions Vitamin Digestive System Preparations Centrifuge Screening Machine Honey Pill Machine Flooring Materials Bearing Emulsifiers Ion-exchange equipment Online Process Control Respiratory System Preparations Sterilizing Equipment TCM Deposition Equipment Spare Part‌ Other Cleaning System Stainless Steel Nervous System Preparations Filter press equipment Herbal medicine Fermentation Equipment Plastic ‌Containment System Special Active Ingredients Ointment Bases Homogenizer Equipment Other TCM Machinery Others Parts and Components APIs for Veterinary Drugs and Feed Additives Anaesthetic and Adjuvant Formulations Air Filter Suppository Bases Other Active Pharmaceutical Ingredients Blood System Formulations Cleanroom Consumables‌ Glass lining equipment Film-forming Agents Urinary and Reproductive System Formulations Other API Machinery and Equipment Filter Paper Release Modifiers Immunomodulatory Formulations Filter Paper Board smotic Pressure Regulators / Tonicity Adjusting Agents Water, Electrolyte, and Acid-Base Balance Regulating Formulations Ph Control Agents Nozzle, Tank Cleaning Machine Vitamin, Mineral, and Amino Acid Formulations Antioxidants / Antioxidant Synergists Fluid Equipment Enzyme and Other Biochemical Formulations Antimicrobial Preservatives (Preservatives) Tonic and Nutritional Formulations Complexing Agents (Chelating Agents / Inclusion Compounds) Hormonal Formulations Dermatological Preparations Other Preparations Co-solvents ENT Preparations Penetration Enhancers (Transdermal) Freeze-drying Protective Agents Refrigerants / Cryogens Capsule Fragrances Adsorbents Pressure-sensitive Adhesives (PSA) Stiffening Agents Carriers for Dry Powder Inhalers (DPI Carriers) Other Excipients

Pipes and Pipe Fittings Vacuum Equipment Air Compressor Compressor Other Fluid Equipment Prefillable Syringes Filters Filter Presstem Filtration System Filter Bag Filter Mesh Filter Cloth Filter Membrane Other Filtration Equipment Sanitary Pressure Vessel‌ Hyaluronic Acid Collagen Botulinum Toxin Peptide Other Injection Raw Materials and Ingredients Ceramide Ectoin Niacinamide Asiaticoside Ergothioneine Chitosan Other Active Ingredients Chiral Intermediates Advanced Intermediates Microfiltration Ultrafiltration Auxiliary Equipment Separation equipment Metered Dose Inhalers Dry Powder Inhalers Penicillin Hormones Central Nervous System Drugs Reagents for Biopharmaceuticals Drug Target Discovery and Validation Plant Extracts Animal Extracts Synthesis/Screening Process Development/Optimisation/Scale-Up Production Drug Registration and Submission Services Ointment Filling-sealing Machine、Vacuum Mixer Eye Drug Machinery Soft Gelatin Capsule Machinery Tablet Press Pneumatic Cracker Granulator Labelers, Label Printers Bag Packaging Machine Thermostatic / Heating / Drying Equipment Chromatography Particle Size / Particle / Powder Analysis Instruments Tabletop Glass bottles & Vials Fermentation Products Prophylactic Biological Products Mixing Tank/Blender Bioreactor Intravenous Infusion Set Assembly Equipment(Pen Assembly Equipment) PCR Recombinant Collagen Alkaloids Veterinary API Regulated Fine Chemicals Peptides Balances / Weighing Scales Online Gas Chromatography Cephalosporins Anesthetics Immunology Reagents Drug Development Technologies Pharmaceutical Chemistry Formulation Design Regulatory and Compliance Consulting Syrup Machinery Injection Medicine Machinery Hard Capsule Filling Machine Coating Machine Medicine Material Grinding Machine Lettering machine Box Packaging Machine Mass Spectrometry Laboratory Bench Aluminum Foil Rheometers / Viscometers ‌Chemical Reagents Cleaning & Disinfection Equipment Granulator Emulsifier Biological Fermentation System Injection Molding Equipment Exosome Phospholipids Prostaglandins Veterinary Biologics Chemical Reagents Therapeutic Biological Products Biochemical Reagents Antibodies Natural Pigments Animal Lipids Enzyme Preparations Flowmeters Online Particle Size Analyzer Tetracycline Amino Acids and Derivatives Process Optimization and Testing Nucleic Acids and Derivatives Pre-Clinical Research Chemical/Biological API Manufacturing Powder Filling Machine Oral Liquid Machinery Low Temperature Pulverizer Strapping machine Paper Film Packaging Machine Thermal Analyzers Spectrometers Other Measurement and Metrology Instruments Storage Cabinets Plastic Bottles Other Industrial Process Control and Online Analytical Instruments Certification Feed Additives Diagnostic Biological Products Pulverizer Coating Machine Capsule Filling Machine Other Mixing Equipment Cell Engineering Equipment Pre-filled Syringe Production Equipment Purification Equipment Electrophoresis/Gel Imaging/UV Detection Regenerative Materials Other Fine Chemicals Cell Biology Reagents Biological Consumables Feed Additives Soft Mist Inhaler Plant Polysaccharides Animal Proteins Microbial Polysaccharides Aminoglycoside Enzymes Molecular Biology Reagents Clinical Trials Intermediate Synthesis and Production Market and Business Strategy Consulting Suppository Drug Machinery Powder Injection Machinery Pharmaceutical Milling Machinery Printing Device Blister Packaging Machine Environmental Test Chambers Moisture Analyzer Air Discharge Equipment Rubber Stopper Tablet Press Other Tablet Equipment Capsule Production Line Isolator Synthesis/Reaction Equipment Microbial Detection Instrument Composite Biomaterials Animal Breeding Auxiliary Products Packaging Testing Equipment Laboratory Glassware and General Consumables Preclinical Research Services Nebulizer Essential Oils Animal Polysaccharides Bioactive Functional Ingredients Macrolides Microbial / Fermentation Reagents Proteins Other Technology Services Biotechnology Services Formulation Development and Manufacturing Other Services Medicine Film Drug Machinery Infusion Medicine Machinery（中文站有输液剂机械的三级分类） Pharmaceutical Machine Milling Instruction Booklet Folding Machine Fan Chromatography Consumables and Accessories Other Physical Properties Testing Instruments Gasket Sample Preparation / Digestion Equipment X-ray Structure Analysis Safety Cabinet Counting Machine (Tablet) Other Capsule Filling Equipment Disposable Biotechnology Equipment Vacuum Packaging Machine Laboratory Low-temperature Storage Other Innovative Materials Other Veterinary Conveying equipment Natural Spices Bile Acids and Active Ingredients Sulfonamides Other Specialized Reagents Computational Chemistry and AI-Assisted Drug Design Clinical Trial Drug Manufacturing Aerosol Drug Machinery Super Micro Mill Bottle Conveyer Bundling Packaging Machine Mixing/Dispersion Equipment Other Laboratory Complete & Ancillary Equipment Trays Other Laboratory Consumable Other Preparation Machinery for Solid Medcine ‌Centrifugal Separation System Automatic Packaging Machine Other Analytical Instrument Chip System/Accessories Cytokines Counting Machine Cartridge Vial Medicinal Herbs Bee Products Chloramphenicols Testing Other Pharmaceutical Manufacturing Outsourcing Medicine Filling Machine Disk Type Bottle Straightening Machine Lidding Materials Other Crushing Equipment Ultrafiltration/Microfiltration System Horizontal Pillow Packaging Machine Cartoning Machine Auto-injector Transfection/Cell Fusion Track & Trace Gas Generators / Gas Handling Equipment Blood Products TCM Ingredients & Slices Animal Medicinal Materials Lincomycin Microbial Products Bottle Washer Vial Sealing Machine Liquid Handling Equipment Hoses and Fittings Other Biopharmaceutical Equipment Vertical Packaging Machine Casing Machine Microplate Reader/Enzyme Labeling Instrument Analysis and Validation Serialization System Pen Injector Other Anti-Infective Drug Other Pharmaceutical R&D Outsourcing Conveyer For Medicine Material Spray Pump Other Injectable Equipment Aluminum Foil Packaging Machine Coding Machine Cell Analysis Automated Assembly Other Laboratory General Equipment Packaging Bag Valve Freeze Dryer Granule packaging machine Other Drug Delivery Device Accessories Biological Microscope/In Vivo Imaging Other Antibiotics Cap Screwing Machine Nasal Drug Delivery Devices / Nasal Spray Pumps Printing Services‌ Liquid Packaging Machine Laboratory Automation Screw Capping Machine Lamp Inspection Machine Ophthalmic Drug Delivery Devices / Eye Drop Delivery Systems Labelling Powder Packaging Machine Synthesizer Heat Shrink Packaging Machine Metal Detector Insulin Pens / Blood Glucose Management Devices Security Taggants & Markings Filter Cartridge‌ Tablet Packaging Machine Animal Experiment Instrument Injection & blow molding machines Batching system Self-Injection Systems / Safety Protection Devices Incubator Equipment Printed Drugs Packaging Box filling & sealing machine Palletizing equipment CIP cleaning system Topical / Gynecological / Intimate Drug Delivery Devices Desiccants Other Life Science Instrument Bottle Filling Line Contaners Lifting Charging Machine Others Inhalant Packaging BFS Bottlepack Machine Weighting Equipment Blister Packaging Machine Pharmaceutical Paper Other Pharmaceutical Outer Packaging Equipment Packaging bag valve Container Sealing Machine Glass Tube Multi-functional Bottle Packaging Machine Medical Aesthetic Freeze-Dried Powder Vials Sachets Cartoner Packing line Primary Packaging Other Pharmaceutical Inner Packaging Equipment Aluminum Caps & Aluminum-Plastic Combination Caps Sterile Bags / Breathing Bags / Sterilization Bags Medical Device Packaging / Bioconsumables Packaging Dispensing Bottles Blister Packaging Pharmaceutical Plastic Films / Composite Film Bags Accessories Ampuls Other Packaging Materials

Products Suppliers Match & Meet

Industry Insights E-Learn Series Pharma Sources Insight

E-trade Season PharmaExpress

Service & Membership Contact Us

CPHI China PMEC China CPHI & PMEC Shenzhen

Home Products Anti-tumor Preparations

Recombinant Human Endostatin

Category:

Anti-tumor Preparations

Standard:

Price Range:

Get Quote

Main Sales Markets:

North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Send inquiry

Jiangsu Simcere Pharmaceutical Co., Ltd.

Years

Show Room

Favorites

Basic Info

Is Manufacturer

Samples Provided

Packaging & Delivery

Packaging Specification

Box Carton

Minimum Order Quantity

1,000 BOX

Product Description

Recombinant Human Endostatin Injection

Generic Name: Recombinant Human Endostatin Injection
Brand name: ENDOSTAR
Composition:
Recombinant Human Endostatin
Description:
Colorless transparent liquid. pH 5.5±0.5
Indications:
ENDOSTAR + NP chemotherapy regimen is used to treat Stage III/IV NSCLC patients either untreated or
pretreated.This indication is based on a completed multi-center Phase III clinical trial (see Clinical Studies).
Strength:
15mg/2.4×105U/3ml/vial
Dose and administration:
Add ENDOSTAR into 250~500ml NS just before the use, drip intravenously at uniform speed for 3~4h.
At combined administration with NP chemotherapy regimen, ENDOSTAR is administered continuously at
7.5mg/m2 (1.2×105U/m2) once a day during Day 1~14 of treatment cycle, and then continues the next
treatment cycle only after the rest for 1 week (generally 2~4 treatment cycles). The physician is recommended
to properly extend its administration time in clinical application within the tolerance of patients.
Adverse Reactions:
During Phase I~III clinical trial, ENDOSTAR is administered in 470 advanced NSCLC patients. The frequent
adverse reactions (1-10%) mainly occurred on heart, and rare adverse reactions (0.1-1%) mainly occurred in
digestive system and skin/annexa allergy.
1. Heart: At the early stage of administration, few patients have mild fatigue, chest distress and palpitation.
In most cases, these symptoms may improve enough so as not to influence the administration continuation
after the symptomatic treatment. But they can persist to discontinue the administration in very few cases. A
minority of cases had to stop the drug for the continuing above-mentioned symptoms. 30 patients (6.38%)
have Degree I/II or mild/moderate cardiologic adverse reactions of mainly myocardial ischemia within Day
2~7 after the administration and posing no dangers to the patient's life. 6.4‰ of these cases have more
evident but reversible symptoms, which does not influence the administration continuation but can alleviate
without any symptomatic treatment. Only 2.1‰ of the cases stop the treatment due to adverse reactions.
In the patients with previous coronary heart disease and hypertension, ENDOSTAR causes the following
frequent cardiologic adverse reactions: sinus tachycardia, mild ST-T change, AV conduction blocking, atrial
premature beat and rare ventricular premature beat. Thus, to guarantee patient safety, regular ECG
examination is recommended for the patient with cardiologic adverse reactions during clinical application.
Patient with previous serious heart diseases must use ENDOSTAR carefully under the guidance of physicians.
2. Digestive System: Rare diarrhea and liver dysfunction (mainly symptom-free transaminase elevation and
jaundice). All these adverse reactions are mainly mild/moderate but rarely serious. Most are reversible and
mild cases do not require symptomatic treatment; Moderate or serious cases may be alleviated through the
slowing of dripping speed or through the proper symptomatic treatment after drug withdrawal; and only few
cases require symptomatic treatment but generally have no influence on administration continuation.
3. Skin/Annexa: The allergy mainly includes reversible systemic maculopapule accompanied with itching
(relievable after drug withdrawal) and mostly mild/moderate fever and fatigue.No death related to adverse
reactions was observed in this multi-center clinical trial on all 470 ENDOSTAR-treated patients.
Contraindications:
Use carefully in the patient with heart/renal hypofunction.
Precautions:
1. Use carefully for the person with allergic constitution or previous allergy to protein biological products;
2. Use carefully for the patient with existing or previous serious heart diseases, including: congestive heart f
ailure, high-risk uncontrollable arrhythmia, angina pectoris requiring drug treatment, valvular disease of definite
clinical diagnosis, serious myocardial infarction on ECG and persistent hypertension. ECG examination shall
be regularly made during its clinical application, ECG monitoring performed for the patients with cardiologic
adverse reactions;
3. This product is colorless transparent liquid, and must not be used in case of abnormalities (such as turbidity
and sediment), broken packaging vial and expired.
4.When the temperature is interrupted(not more than 20ºC)during storage and transportation,the time should
not exceed 7 days,and freezing,illumination or heating shoule be avoided.
Pregnancy and lactation:
Never used in pregnant and lactating women, no previous animal experiment on its genital toxicity. Thus, use
only under the close supervision of physicians.
Pediatric use:
No previous clinical trial on its administration in pediatric patients. Used only if medication is absolutely needed
and only under the guidance of physicians.
Geriatric use:
Use only under the close observation of physicians for the old tumor patients with previous serious heart disease.
Drug interactions:
No previous systematic research on its interaction with other drugs. During the clinical application, do not mix
with other drugs or solutions possibly influencing its pH value.
Overdose:
In this clinical trial, the above-mentioned adverse reactions occur after the single intravenous drip of 30~210
mg/m2 (4.8×105~33.6×105U/m2) or after the continuous intravenous drip of 7.5~30mg/m2 (1.2×105~4.8×10
5U/m2) for 28d. There is no clinical data of higher dose.
See under section of Adverse Effect.
Clinical studies:
The National Clinical Trial Center for New Drugs (Anti-Tumor) of Cancer Hospital, Chinese Academy of
Medical Sciences, led a research team to jointly conduct a multi-center clinical trial.
Single-drug Administration: Phase II clinical trial (single-drug administration) adopts the randomly controlled,
open-labeled and multi-center research method. It mainly assesses the efficacy of ENDOSTAR, compares
the dose-efficacy relation and safety difference of 7.5mg/m2 (1.2×105U/m2) and 15mg/m2 (2.4×105U/m2),
and thus determines the optimum effective dose for clinical application. All subjects are retreated tumor p
atients pathologically and/or cytologically diagnosed definitely as non-small-cell lung cancer (NSCLC). The
subjects are divided into 7.5mg/m2 and 15mg/m2 dose group at intravenous drip for 3~12h once a day
continuously for 28d respectively. After the completion of administration, the efficacy is assessed according
to the Efficacy Evaluation Criterion on Solid Tumor (WHO). A total of 8 hospitals participates in this trial to o
bserve 68 NSCLC patients, among which 60 patients complete efficacy assessment (Table 1).
Recombinant Human Endostatin

Combination treatment: A randomly controlled, double-blind and multi-center Phase III clinical trial is made on
the combined administration of ENDOSTAR and NP regimen in 493 advanced NSCLC patients.Administration
regimen of test group: 25mg/m2 NVB at Day 1 and Day 5; 30mg/m2 DDP at Day 2, Day 3, and Day 4; and
7.5mg/m2 (1.2×105U/m2) ENDOSTAR continuously during Day 1~14. Administration regimen
of control group: 25mg/m2 NVB at Day 1 and Day 5; 30mg/m2 DDP at Day 2, Day 3, and Day 4; and normal
saline (NS) during Day 1~14. The endpoint research index includes: response rate(CR+PR/total cases×100%)
clinical benefit rate (CR+PR+MR+SD/total cases×100%), TTP, median survive time, one-year survival rate,
quality of life (QOL) and safety. There are 486 cases with evaluable efficacy, i.e. test group: control
group =322:164 (cases), and untreated: pretreated =347:139 (cases). (Table 2) .

Recombinant Human Endostatin

Pharmacology and toxicology:
1. Pharmacological action
Rh-Endostatin is a new angiogenesis-inhibiting biological product. It inhibits the metastasis of angiogenesis
endothelial cells, inhibits the formation of tumor new blood vessel, obstructs the nutrition supply of tumor cells,
and thus inhibits the proliferation or metastasis of tumor.As shown by in vitro test results, ENDOSTAR inhibits
the metastasis of HHEC and the formation of Tube, significantly inhibits the angiogenesis of chicken embryo
allantoic membrane. Thus, ENDOSTAR suppresses angiogenesis in vitro to a certain extent. In addition, it
inhibits the growth of human lung adenocarcinoma cells SPC-A4 to a certain extent.As shown by in vivo test
results, ENDOSTAR has extensive effects of inhibiting the mouse tumor model (S180 sarcoma, H22 liver
cancer) and human xenograft tumor (SPC-A4 lung adenocarcinoma, SGC7901 stomach cancer, Hela cervical
carcinoma, SMMC-7721 and Bel7402 liver cancer).
2. Toxicological action
General Pharmacology: After the intravenous injection of 1.5, 3 and 6mg/kg (2.4×104 - 4.8×104, and 9.6×104
U/kg)(high, medium and low dose group) , such parameters as blood pressure, respiration, and ECG index,
etc. of anaesthetized dog remains same to those before the injection, and the autonomic activity frequency
of mouse is not influenced.Hemolysis, Irritation,Allergy in Animal: There is no hemolysis or hemagglutinationin
during the observationtime after the administration of 0.08mg/ml ENDOSTAR; guinea-pig had no allergic
reactions after first the intraperitoneal injection of 0.5ml/guinea-pig (0.036mg/ml) every other day continuously
for 3 times and then the 1ml/guinea-pig (0.036mg/ml) 14d and 21d after the first administration; and rabbit had
no evident irritant reactions (such as vasodilatation and red swelling) or morphological changes (as vascular
wall thickening) in venous irritation test.
Acute Toxicity: Mouse had a LD50 of more than 450.5mg (7.2×106 U)/kg after the intravenous or
intraperitoneal administration of ENDOSTAR.
Long-term Toxicity: As shown by long-term toxicity test on rat, at the end of 21d after the withdrawal of
continuous intraperitoneal injection of 3, 6, and 12mg/kg/day (4.8×104, 9.6×104, and 19.2×104U/kg/day) for
45d respectively, all these three dose groups are not significantly different from control group in the
pathomorphological changes of internal organs (such as heart, liver, spleen, lung, brain, stomach, small
intestine, uterus and testicle).
As shown by long-term toxicity test on beagle dog, after the continuous intravenous injection of 2, 10 and
25mg/kg/day (3.2×104, 16.0×104, and 40.0×104U/kg/day) for 13 weeks respectively, beagle dog does not
have evident toxic reactions on target organs or delayed toxic reactions, but only have the adverse reaction
of elevated reticuloerythrocyte which is reversible after the drug withdrawal.
As shown by long-term toxicity test on rhesus, after the continuous intravenous injection of 3mg (4.8×104U)/
kg/day (50.4mg/m2), 10mg(1.6×105U)/kg/day (167.9mg/m2), and 30mg (4.8×105U)/kg/day (503.7mg/m2)
continuously for 9 months respectively, each dose group had no evident abnormal change in vital signs,
appearance behavior, and activities; its examination results fluctuated within the range of normal value for
weight, food intake, and hematological/blood biochemical/ECG/urine examination (i.e. no evident impairment
liver and renal function; it had basically normal protein, fat, and glucose metabolism; and it is not significantly
different in organ coefficient and had no dose-related abnormal change according to the histopathological
results. In brief, no evident toxic reactions occur after the continuous intravenous injection of less than 30mg
(4.8×105U)/kg/day, and thus such dose range is safe for ENDOSTAR.
Pharmacokinetics:
After the single intravenous drip of 30mg (4.8×105U)/m2 and 60mg (9.6×105U)/m2 within 30min (at a speed
of 1 and 2mg/m2/min respectively) and of 120mg (19.2×105U)/m2 and 210mg (33.6×105U)/m2 within 120min
(at a speed of 1 and 1.75mg/m2/min respectively) in health volunteer, ENDOSTAR has a terminal clearance
half-life (t1/2) of about 10h and a systemic clearance rate (CLs) of about 2.8L/h/m2. In normal human body,
ENDOSTAR follows approximately the linear pharmacokinetics within the dose range of 30~120mg/m2 (4.8×
105~19.2×105U/m2). The linear model can be used to predict the blood drug concentration at different total
dose, dripping speed and dripping time, which can influence AUC and maximum concentration level.
In tumor patient, ENDOSTAR shows great inter-individual difference in drug concentration-time curve after the
daily intravenous drip within 2h continuously for 28d.The minimum concentration tends to increase continuously
with the increase in administration times, and both total dose and dripping times can influence both the peak
and trough concentrations.
After the intravenous administration of in normal mouse, the drug concentration is highest in urinary excretory
system, higher in kidney, urine, lung and liver than in plasma, lower in other tissues than in plasma, and lowest
in muscle, fat, and brain. After the intravenous injection in tumor mouse, the systemic distribution ENDOSTAR
is similar to that in normal mouse, its low distribution in tumor tissue is similar to that in muscle and fat tissue.
Antibody generation:
The antibody IgG serum is detected through indirect ELISA method the intravenous injection of ENDOSTAR
continuously for 9 months in rhesus. The antibody generated after the administration is related to both dose
and time: the higher dose generates the higher-titer antibody in more rhesuses. The antibody can be detected
1 month after the administration. The antibody titer varies with time: more stable in first 3 months before the
administration, and less and even no at Month 5, 7, 9, and 10. As analyzed through the cell viability detection
method, the ENDOSTAR viability in serum does not change at all, and thus the generated antibody is not
neutralizing antibody.Various ENDOSTAR antibodies (IgA, IgG, IgM, and IgE) and His-tag antibody are
detected through the same above antibody detection method in patient serum. 31 subjects undergo this
detection, including 20 cases from treatment group and 11 cases from control group. In treatment group,
2 cases have positive ENDOSTAR IgA on Day 32 and Month 24 respectively, and 1 case had positive His-tag
IgA, both at a titer of 1:10. In control group, 2 cases have positive IgG at a titer of 1:10. Any other patient does
not have antibody reaction after the treatment. The in vitro test on low-titer (1:10) serum antibody does not
show any biological activity to neutralize ENDOSTAR.
Storage:
Keep at 2~8ºC in a dark place
Package:
Filled in 3.0ml Pre-embedded syringe.
Shelf-life:
18 months